Asian Stocks Rise Amid China Trade, Inflation Focus by Mark Eisenberg 25.06.2024 Asian stocks make modest gains as investors focus on China trade tensions and key inflation data. Markets are cautious but ...
Australia Consumers Juggle Budget Relief, Rate Risks by Mark Eisenberg 25.06.2024 "Australian consumer sentiment rises 1.7% in June due to tax cut promises. Yet fears of inflation and higher mortgage rates ...
Salesforce Exec Tallapragada Sells $228K in Shares by Mark Eisenberg 25.06.2024 Salesforce exec Srinivas Tallapragada sells $228K in shares to cover taxes; Salesforce sees 11% revenue rise, strong market position, and ...
Enerpac Slides 9% on Q3 Revenue Miss – Strong Balance Sheet by Mark Eisenberg 25.06.2024 Enerpac shares dropped 9% after a Q3 revenue miss despite EPS meeting expectations and improvements in gross margin and EBITDA.
Brazil Stocks Climb: Bovespa Index Gains 1.07% by Mark Eisenberg 25.06.2024 "Brazil Stocks Rally with Bovespa Up 1.07%; Top Gainers Include Magazine Luiza, MRV Engenharia. Market Stability Evident as Volatility Drops."
HireQuest CEO Buys $12.9K in Stock Amid Market Struggles by Mark Eisenberg 25.06.2024 HireQuest CEO buys $12.9K in shares, signaling strong confidence in company’s future amidst tough market and positive Q1 financials.
Kaltura Exec Sells $2,278 in Stock Amid Planned Strategy by Mark Eisenberg 25.06.2024 Kaltura's Chief Customer Officer Natan Israeli sells company stock under a 10b5-1 plan, retaining a strong shareholding, reflecting confidence in ...
Old School Crypto Staking vs. Restaking Craze: Investor Insights by John Darbie 25.06.2024 Discover how traditional crypto staking offers high yields and simpler investment strategies compared to the new restaking trend in digital ...
Sonendo Exec Sells Stock; Details on 2024 Revenue Guidance by Mark Eisenberg 25.06.2024 Sonendo’s Chief Talent Officer Roy T. Chen sells $700+ in stocks to cover tax obligations on RSU vesting, maintaining significant ...
CTT Pharma CEO Buys $70 in Stock, Owns 5M+ Shares by Mark Eisenberg 25.06.2024 CTT Pharmaceutical CEO buys $70 in stock, signaling confidence. Despite recent gains, profitability concerns remain. Investors should monitor closely.